These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 26952562)
1. Pleomorphic rhabdomyosarcoma with an impressive response to chemotherapy: case report and review of the literature. Kollár A; Langer R; Ionescu C; Cullmann JL; Klenke FM Tumori; 2016 Nov; 102(Suppl. 2):. PubMed ID: 26952562 [TBL] [Abstract][Full Text] [Related]
2. Primary rhabdomyosarcoma of urethra in a 5-year-old girl: case report and literature review. Liu AX; Zhou JH; Jin HM; Zhu CK; Cheng XD Urology; 2007 Jun; 69(6):1208.e17-9. PubMed ID: 17572220 [TBL] [Abstract][Full Text] [Related]
3. Para testicular rhabdomyosarcoma in adults: three case reports and review of literature. Boudahna L; Benbrahim Z; Amaadour L; Mazouz A; Benhayoune K; Tahiri Y; Farih MH; Amarti A; Arifi S; Mellas N Pan Afr Med J; 2014; 19():279. PubMed ID: 25870734 [TBL] [Abstract][Full Text] [Related]
4. Successful treatment of synchronous chemoresistant pulmonary metastasis from pleomorphic rhabdomyosarcoma with stereotaxic body radiation therapy: A case report and a review of the literature. Benkhaled S; Mané M; Jungels C; Shumelinsky F; Aubain NS; Van Gestel D Cancer Treat Res Commun; 2021; 26():100282. PubMed ID: 33360328 [TBL] [Abstract][Full Text] [Related]
6. Prognostic Factors and Treatment Outcomes of Adult Patients With Rhabdomyosarcoma After Multimodality Treatment. Liu YT; Wang CW; Hong RL; Kuo SH Anticancer Res; 2019 Mar; 39(3):1355-1364. PubMed ID: 30842169 [TBL] [Abstract][Full Text] [Related]
7. Case of pleomorphic rhabdomyosarcoma arising on subcutaneous tissue in an adult patient: Review of the published works of 13 cases arising on cutaneous or subcutaneous tissue. Watanabe M; Ansai SI; Iwakiri I; Fukumoto T; Murakami M J Dermatol; 2017 Jan; 44(1):59-63. PubMed ID: 27569112 [TBL] [Abstract][Full Text] [Related]
9. Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group. Weigel BJ; Lyden E; Anderson JR; Meyer WH; Parham DM; Rodeberg DA; Michalski JM; Hawkins DS; Arndt CA J Clin Oncol; 2016 Jan; 34(2):117-22. PubMed ID: 26503200 [TBL] [Abstract][Full Text] [Related]
10. Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to III. Wolden SL; Anderson JR; Crist WM; Breneman JC; Wharam MD; Wiener ES; Qualman SJ; Donaldson SS J Clin Oncol; 1999 Nov; 17(11):3468-75. PubMed ID: 10550144 [TBL] [Abstract][Full Text] [Related]
11. Sarcoma of the prostate: a single institutional review. Janet NL; May AW; Akins RS Am J Clin Oncol; 2009 Feb; 32(1):27-9. PubMed ID: 19194120 [TBL] [Abstract][Full Text] [Related]
12. Treatment of adult rhabdomyosarcoma. Ogilvie CM; Crawford EA; Slotcavage RL; King JJ; Lackman RD; Hartner L; Staddon AP Am J Clin Oncol; 2010 Apr; 33(2):128-31. PubMed ID: 19770626 [TBL] [Abstract][Full Text] [Related]
13. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group. Meza JL; Anderson J; Pappo AS; Meyer WH; J Clin Oncol; 2006 Aug; 24(24):3844-51. PubMed ID: 16921036 [TBL] [Abstract][Full Text] [Related]
14. [Treatment of rhabdomyosarcoma at the National Cancer Center Hospital]. Beppu Y; Fukuma H; Chuma H; Ise T; Ohira M Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1603-13. PubMed ID: 3592704 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of topotecan and cyclophosphamide given in a phase II window trial in children with newly diagnosed metastatic rhabdomyosarcoma: a Children's Oncology Group study. Walterhouse DO; Lyden ER; Breitfeld PP; Qualman SJ; Wharam MD; Meyer WH J Clin Oncol; 2004 Apr; 22(8):1398-403. PubMed ID: 15007087 [TBL] [Abstract][Full Text] [Related]
16. Comparison of dose intensity of vincristine, d-actinomycin, and cyclophosphamide chemotherapy for child and adult rhabdomyosarcoma: a retrospective analysis. Kojima Y; Hashimoto K; Ando M; Yonemori K; Yamamoto H; Kodaira M; Yunokawa M; Shimizu C; Tamura K; Hosono A; Makimoto A; Fujiwara Y Cancer Chemother Pharmacol; 2012 Sep; 70(3):391-7. PubMed ID: 22806306 [TBL] [Abstract][Full Text] [Related]
17. Paranasal sinus rhabdomyosarcoma: a rare tumor of poor prognosis. El Sanharawi A; Coulibaly B; Bessede JP; Aubry K Eur Ann Otorhinolaryngol Head Neck Dis; 2013 Feb; 130(1):26-9. PubMed ID: 23021978 [TBL] [Abstract][Full Text] [Related]
18. Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma--a report from the Intergroup Rhabdomyosarcoma Study IV. Breneman JC; Lyden E; Pappo AS; Link MP; Anderson JR; Parham DM; Qualman SJ; Wharam MD; Donaldson SS; Maurer HM; Meyer WH; Baker KS; Paidas CN; Crist WM J Clin Oncol; 2003 Jan; 21(1):78-84. PubMed ID: 12506174 [TBL] [Abstract][Full Text] [Related]
19. The VAC regimen for adult rhabdomyosarcoma: Differences between adolescent/young adult and older patients. Nakano K; Ae K; Matsumoto S; Takahashi S Asia Pac J Clin Oncol; 2020 Apr; 16(2):e47-e52. PubMed ID: 31657883 [TBL] [Abstract][Full Text] [Related]
20. Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group. Koscielniak E; Klingebiel TH; Peters C; Hermann J; Burdach ST; Bender-Götze C; Müller-Weihrich ST; Treuner J Bone Marrow Transplant; 1997 Feb; 19(3):227-31. PubMed ID: 9028550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]